Prenatal Drug Exposure

Follow

• 

  Prenatal Substance Exposure and Positive Developmental Delay Screening Among Patients in Foster Care

  Lauren Malthaner, Jill McLeigh, Gregory Knell, Katelyn Jetelina, Folefac Atem, and S Messiah

  Prenatal substance exposure (PSE) is a known risk factor for negative birth outcomes and long-term health outcomes like neurodevelopmental problems. Children in foster care have increased exposure to PSE and higher proportions of developmental delay compared with the general population. It is unclear whether differences still exist among developmental delay screening among children in foster care with and without PSE.

  Children in foster care with PSE are at risk for positive developmental delay screening compared with those without; however, those with both PSE and prematurity are at extra risk. This interaction should be considered when making inferences regarding developmental delay screening in this population.

• 

  Healthcare utilization among children with a history of neonatal opioid withdrawal syndrome: A matched cohort study

  Lauren Malthaner, Jill McLeigh, Hilda Loria, and Katelyn Jetelina

  Compare longitudinal healthcare utilization patterns in children with and without a history of neonatal opioid withdrawal syndrome (NOWS).

• 

  Foster Parent Perceptions of Feeding Infants Prenatally Exposed to Substance Use

  Sara Moore

  The Foster Parent Perceptions project framework utilized Ajzen’s Theory of Planned Behavior. This project aimed to investigate changes in Foster Parent Perceptions concerning feeding the infant prenatally exposed to substances. The project outcomes reinforced that foster parent perceptions change with topic-specific education. Focusing on foster parent education—before placing an infant who was vulnerable into the home—increased the foster parent’s toolbox of skills and promoted the potential that the infant would thrive in their environment.